Panniculitis after vaccination against CEA and MUC1 in a patient with pancreatic cancer.
Kaufman
Howard L
HL
Department of Surgical Oncology, Columbia University, New York, NY, USA. hlk2003@columbia.edu <hlk2003@columbia.edu>
Harandi
Amir
A
Watson
Matthew C
MC
Carter
Eric L
EL
DeRaffele
Gail
G
Shahid
Mohammad
M
Fine
Robert L
RL
D000230:Adenocarcinoma / Q000556:secondary / Q000628:therapy*; D000368:Aged; D019496:Cancer Vaccines / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy*; D008297:Male; D018396:Mucin-1 / Q000009:adverse effects; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*; D015434:Panniculitis / Q000139:chemically induced / Q000175:diagnosis*; D010446:Peptide Fragments / Q000009:adverse effects
D019496:Cancer Vaccines; C116055:MUC1 tandem repeat peptide; D018396:Mucin-1; D010446:Peptide Fragments